American Journal of Clinical Nutrition, Vol 66, 342-346, Copyright © 1997 by The American Society for Clinical Nutrition, Inc

ORIGINAL RESEARCH COMMUNICATIONS

Percentile estimates for transferrin receptor in normal infants 9-15 mo of age

GS Yeung and SH Zlotkin
Department of Pediatrics, University of Toronto, Canada.

To establish percentile estimates of transferrin receptor (TfR) for healthy infants, plasma TfR was measured in 485 healthy infants 9-15 mo of age from Edmonton, Toronto, Montreal, and Halifax. Education and income of the sample families were reflective of the average family based on the 1991 census estimates. The mean (+/-SD) plasma TfR concentration was 4.4 +/- 1.1 mg/L. As expected in the infant population, there were no differences in TfR concentrations as a result of sex, and within this small age range there was no significant change across age. Furthermore, the TfR concentration in plasma was not associated with hemoglobin, serum ferritin, or free erythrocyte protoporphyrin. TfR has been shown to be a sensitive, quantitative measure of tissue iron deficiency not affected by inflammation and is potentially important in the diagnosis of iron deficiency, but there is a lack of normative data, particularly in infants, who are at highest risk of iron deficiency. If TfR proves useful in the diagnosis of iron deficiency, the current data will be useful as a reference standard for healthy infants.

This article has been cited by other articles:

				J. M. Brotanek, J. Gosz, M. Weitzman, and G. Flores Secular Trends in the Prevalence of Iron Deficiency Among US Toddlers, 1976-2002 Arch Pediatr Adolesc Med, April 1, 2008; 162(4): 374 - 381. [Abstract] [Full Text] [PDF]

				J. M. Brotanek, G. Flores, and M. Weitzman Iron-Status Indicators: In Reply Pediatrics, March 1, 2008; 121(3): 652 - 652. [Full Text] [PDF]

				M. Wijaya-Erhardt, J. G Erhardt, J. Untoro, E. Karyadi, L. Wibowo, and R. Gross Effect of daily or weekly multiple-micronutrient and iron foodlike tablets on body iron stores of Indonesian infants aged 6 12 mo: a double-blind, randomized, placebo-controlled trial Am. J. Clinical Nutrition, December 1, 2007; 86(6): 1680 - 1686. [Abstract] [Full Text] [PDF]

				G. Hay, H. Refsum, A. Whitelaw, E. L. Melbye, E. Haug, and B. Borch-Iohnsen Predictors of serum ferritin and serum soluble transferrin receptor in newborns and their associations with iron status during the first 2 y of life Am. J. Clinical Nutrition, July 1, 2007; 86(1): 64 - 73. [Abstract] [Full Text] [PDF]

				P. Suominen, A. Virtanen, M. Lehtonen-Veromaa, O. J. Heinonen, T. T. Salmi, M. Alanen, T. Mottonen, A. Rajamaki, and K. Irjala Regression-based Reference Limits for Serum Transferrin Receptor in Children 6 Months to 16 Years of Age Clin. Chem., May 1, 2001; 47(5): 935 - 937. [Full Text] [PDF]

				M. Olivares, T. Walter, J. D Cook, E. Hertrampf, and F. Pizarro Usefulness of serum transferrin receptor and serum ferritin in diagnosis of iron deficiency in infancy Am. J. Clinical Nutrition, November 1, 2000; 72(5): 1191 - 1195. [Abstract] [Full Text] [PDF]

				A. Singhal, R. Morley, R. Abbott, S. Fairweather-Tait, T. Stephenson, and A. Lucas Clinical Safety of Iron-Fortified Formulas Pediatrics, March 1, 2000; 105(3): 38e - 38. [Abstract] [Full Text]

				J. W. Choi, S. H. Pai, M. W. Im, and S. K. Kim Change in Transferrin Receptor Concentrations with Age Clin. Chem., September 1, 1999; 45(9): 1562 - 1563. [Full Text] [PDF]